In order to analyze whether epithelial to mesenchymal transition (EMT) affects metabolic pathways in GBMs, we established stable tumor models with suppressed expression of the core EMT activator ZEB1 in three GBM cell lines (LN229, GBM1 and JHH520) through RNA interference technology. The gene discussed is ZEB1; the disease is glioblastoma.